28 citations
,
November 2014 in “Current Diabetes Reports” Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.
14 citations
,
January 2008 in “Gynecological Endocrinology” High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.
1 citations
,
February 2025 in “Journal of Pharma Insights and Research.” Polycystic Ovarian Disease (PCOD) is a complex endocrine disorder affecting women of reproductive age, characterized by symptoms such as irregular menstruation, hormonal imbalances, and insulin resistance. While conventional treatments are primary, nutraceuticals have shown promise as complementary therapies. Compounds like Ashwagandha, Cinnamon, Fenugreek, and Holy Basil have demonstrated potential in addressing PCOD's pathophysiological aspects through hormone regulation, insulin sensitization, and anti-inflammatory effects. Clinical evidence indicates that these nutraceuticals can improve menstrual regularity, reduce androgen levels, and enhance insulin sensitivity. Additionally, Chaste berry, Licorice, and Aloe vera may help manage specific PCOD symptoms.
2 citations
,
September 2020 in “Swedish Journal of BioScience Research” Chitosan from Lucilia cuprina improves wound healing in diabetic mice treated with insulin.
1 citations
,
November 2017 in “International journal of clinical endocrinology and metabolism” The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.